Goodwin
Michael Shuster
- Deals
- 2
- Latest
- Feb 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 2 deals
Often works with
- Maria C. Smith 1 deal together
- Kuwabo Mubyana 1 deal together
- Christopher Bodle 1 deal together
- Catherine Amaya 1 deal together
- Chris McKenna 1 deal together
- Vicki Vann 1 deal together
- Danielle Moten 1 deal together
- Tavid Bingham 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Feb 2026 | Orna Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Orna Therapeutics (target) | Announced | 2,400.0 | Biotech+1 | Eli Lilly and Company acquisition of Orna Therapeutics |
| Jan 2026 | Aktis Oncology | – | – | IPO | Legal adviser to the issuer | Listed | 317.7 | Biotech+2 | Aktis Oncology IPO |
Deals where Michael Shuster is named on the firm's deal team, by the firm or the press.